MarketsandMarkets – Market Research Reports

Tuesday, August 31, 2010

New Report Top 25 OTC Drugs Market (2010 - 2015) Published By MarketsandMarkets

Original Source: OTC Drugs Market
Buy Now: OTC Drugs Market

Over the counter drugs can be broadly segmented as analgesics, topical medicines, cough and cold preparations, indigestion preparations, medicated skin products, first aid kits, plaster and bandages, traditional medicines and vitamins and minerals. Among all the OTC drugs cough and cold preparations lead the OTC healthcare market with almost 18% of market share. Johnson& Johnson, GlaxoSmithKline Plc and Novartis AG are the leading players of global OTC market.

Browse in-depth ToC on Top 25 OTC Drugs Market (2010 – 2015)
Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/OTC-drug-255.html

By 2015, OTC drugs market is expected to generate revenues of more than $70 billion and grow by about 16% from its level of $60 billion in 2009. Shift from Rx-to-OTC and growing demand in emerging countries are likely to be the major drivers for growth of this industry. The reports can provide heads on the recent markets trends of top twenty five products driving the OTC drugs market, their sales forecast growth drivers and barriers, competitive landscape, market shares and geographic analysis.

About:
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategic advisory reports and serve as a business intelligence partner to Fortune 500 companies across the globe. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M Banking and Financial Services Practice recognize the challenges that financial institutions face while bringing the right products to market. Our reports and consulting practice provides a unique perspective allowing financial institutions to understand and strategize to achieve their product goals. Through a mix of case studies, primary research, and business modeling we provide a 360° view to identify how our clients can create, capture, and retain the value of their products and outthink the competition.

Contact:
Ms. Sunita
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com
http://www.marketsandmarkets.com
http://marketsandmarkets.wordpress.com/
http://marketsandmarkets.blogspot.com/

New Report Clinical Trials Market in Brazil, Russia, India, India (BRIC) (2010 - 2015) Published By MarketsandMarkets

Original Source: Clinical Trials Market
Buy Now: Clinical Trials Market

Clinical trials market is evidencing a significant growth in emerging economies. India, especially is illustrating significant growth rate due to its large patient base with diverse gene pool that allows the Pharma companies and CROs to conduct clinical trials in more effective method. The average cost savings in conducting clinical trials in BRIC economies extends from 20% to 60%. However, increased interaction and review of ethical committees and training would provide cohesive environment that can further boost the market for clinical trials in developing economies.

Browse in-depth ToC on Clinical Trials Market in Brazil, Russia, India, India (BRIC) (2010 – 2015)
Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/clinical-trials-260.html

New Report Monoclonal Antibodies Market (2010 - 2015) Published By MarketsandMarkets

Original Source: Monoclonal Antibodies Market
Buy Now: Monoclonal Antibodies Market

The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008. Monoclonal antibodies present significant opportunities as they are targeted therapy (They impact only the diseased cells and do not harm healthy cells) unlike chemotherapy drugs. This results in reduced side effects and increased effectiveness. Cancer in one of the significant application area for mAbs. However, price correction would enable significant shift of usage from traditional chemotherapy drugs to mAbs

Browse in-depth ToC on Monoclonal Antibodies Market (2010 – 2015)
Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/monoclonal-antibodies-261.html

New Report Health Care Information Technology (HCIT) Market in BRIC (Brazil, Russia, India, China) 2010-2015 Published By MarketsandMarkets

Original Source: Health Care Information Technology
Buy Now: Health Care Information Technology

Countries such as Brazil, India, China and Russia are moving ahead to adopt such modern technologies to minimize healthcare cost and to provide primary and secondary healthcare services to large rural population. Technology driven healthcare programs such as Telemedicine projects are growing in all four countries. Such projects are increasing use of healthcare information technology. Since these countries are still in emerging stage in terms of HCIT usage hence it is essential to start with basic healthcare IT solutions such as EMR’s and CPOE. These technologies in their basic form can be easily implemented at minimal cost, at least in urban healthcare institutions. Government initiatives towards healthcare system development and modernization are the major reasons behind HCIT growth in these countries.

Browse in-depth ToC on Health Care Information Technology (HCIT) Market in BRIC (Brazil, Russia, India, China) 2010-2015
Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/health-care-information-technology-252.html

Table of Content

1.Introduction

1.1.Key take away

1.2.Report description

1.3.Market covered

1.4.Stakeholder

1.5.Research Methodology

2.Summary

3.Market overview

4.Healthcare information technology in BRIC counties

4.1 Market overview

4.2 Drivers, restraints and opportunities

5.Healthcare IT market segments in BRIC countries

5.1.By healthcare information technology applications market in BRIC countries

5.1.1.Market overview

5.1.2.Driver, restraints and opportunities in BRIC

5.1.3.General applications

5.1.1.1EMR

5.1.1.2EHR

5.1.1.3CPOE

5.1.4.Hospital application market

5.1.5.Laboratory information system

5.1.6.Clinical information system

5.1.7.Other applications

5.1.8.Imaging systems

5.1.8.1 RIS

5.1.8.2 PACS

5.2.Health information technology by services in BRICS countries

5.2.1.Telemedicine market overview

5.2.1.1.Drivers, Restraints and opportunities (BRIC)

5.2.1.2.Consulting services

5.2.1.3.Implementation services

5.2.1.4.Training services

5.3.Health information technology by products in BRICS countries

5.3.1.Market overview

5.3.2.Drivers, Restraints and opportunities (BRIC)

5.3.3.Software market

5.3.4.Hardware market

6.Geographic analysis

6.1 Brazil

6.2 Russia

6.3 India

6.4 China

7.Competitive landscape

8.Company profiles

New Report Global Pediatric Healthcare Market (2010 - 2015) Published By MarketsandMarkets

Original Source: Pediatric Healthcare Market
Buy Now: Pediatric Healthcare Market

Children often suffer from short term diseases related to respiratory or ocular infections. Apart from these, gastrointestinal infections accompanied by diarrhea and injury related disorders are common in children. Many times these are just short term diseases and treated on daily basis by pediatricians but treatment of these diseases consume large amount of time and financial resources of their parents and caregivers involved in primary care. Change in lifestyle has been a major factor for increased prevalence of such diseases.

Browse in-depth ToC on Global Pediatric Healthcare Market (2010 – 2015)
Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/pediatric-healthcare-256.html

While many are of short term nature, some chronic diseases such as asthma and allergies, diabetes, obesity, cerebral palsy and other neurological disorders such as epilepsy result in chronic illness which requires long term treatments.

Global pediatric healthcare market is expected to grow at CAGR of 7.2% from $65.8 billion in 2010 to $81 billion by 2013. At the same time chronic illness segment is expected to show CAGR of 8.6% and reach $59 billion market in 2013 from $46 billion in 2010. The growing demand of treatment options for chronic illness makes the pediatric healthcare market lucrative to invest, and this report helps to gain heads on the in depth analysis of various developments, market trends, drivers, restrains, opportunities , sales forecast and competitive landscape in this market.